investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Biomarkers of Opisthorchis Viverrini-Induced Cholangiocarcinoma
Paul J Brindley
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Jason Mulvenna
James Cook University
Townsville, Australia
Banchob Sripa
Khon Kaen University
Khon Kaen, Thailand
Jeffery Bethony
George Washington University
Washington D.C., United States
Paul J Brindley
George Washington University
Washington D.C., United States
Related projects
Jeffrey N Martin
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer - Uganda, Kenya, San Francisco
Liver and intrahepatic bile ducts
Pathology
Banchob Sripa
Pathogenesis, Carcinogenesis and Ecology of Opisthorchiasis in Thailand
Liver and intrahepatic bile ducts
Pathology
Jean-Francois H Geschwind
See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization Drug Delivery
Liver and intrahepatic bile ducts
Pathology
Marshall Hicks
Clinical Relevance of FGF19 Signaling in the Resistance to Image-guided Therapy in Hepatocellular Carcinoma
Liver and intrahepatic bile ducts
Pathology
Richard T D'Aquila
Third Coast Center for AIDS Research
Liver and intrahepatic bile ducts
Pathology
Ahmed Kaseb
Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepateocellular Carcinoma
Liver and intrahepatic bile ducts
Pathology
Gregory D Kirk
HIV and Hepatocellular Carcinoma in Uganda: The H2U Consortium
Liver and intrahepatic bile ducts
Pathology
Jean-Francois H Geschwind
See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization DrugDelivery
Liver and intrahepatic bile ducts
Pathology
Jian-Min Yuan
Prospective Studies of Cancer Etiology and Prevention in Shanghai and Singapore
Liver and intrahepatic bile ducts
Pathology
